{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T06:22:09Z","timestamp":1787898129298,"version":"build-2784847793"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R37CA258730"],"award-info":[{"award-number":["R37CA258730"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA288820"],"award-info":[{"award-number":["R01CA288820"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA292949"],"award-info":[{"award-number":["R01CA292949"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"crossref","award":["25CHAL05"],"award-info":[{"award-number":["25CHAL05"]}],"id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"crossref","award":["17YOUN12"],"award-info":[{"award-number":["17YOUN12"]}],"id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Yale Cancer Center CCSG Pilot Grant","award":["P30CA016359"],"award-info":[{"award-number":["P30CA016359"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hormone-dependent cancers such as prostate, breast, and endometrial carcinomas rely on nuclear hormone receptors to sustain lineage identity and growth. Therapies targeting androgen, estrogen, or progesterone signaling are initially effective but ultimately impose selective pressures that drive resistance through lineage plasticity, the ability of tumor cells to abandon their native identity and adopt alternative cellular fates. While the biological consequences of lineage plasticity are increasingly recognized, a major challenge lies in defining the regulatory programs that govern these cell fate transitions and determine their stability, directionality, and therapeutic vulnerability. In this review, we focus on the regulatory modules that underlie lineage plasticity in hormone-driven cancers. We highlight how integrative multi-omics approaches spanning genomic, transcriptomic, epigenomic, proteomic, and chromatin-level layers have enabled the identification of transcriptional and epigenetic programs that destabilize lineage fidelity. We discuss how single-cell and spatial technologies have revealed intermediate states, rare subpopulations, and microenvironmental influences that shape plasticity trajectories. Finally, we emphasize the role of artificial intelligence and machine learning as integrative tools to reconstruct gene regulatory circuits, infer fate transitions, and connect molecular programs to phenotypic outcomes. By synthesizing these biological insights across experimental and computational modalities, we propose a conceptual framework for understanding lineage plasticity in hormone-driven cancers, with emphasis on prostate and breast malignancies. This integrated perspective highlights how regulatory programs governing cell identity can be revealed, perturbed, and potentially constrained, offering opportunities to identify biomarkers, expose therapeutic vulnerabilities, and ultimately translate mechanistic understanding into strategies that limit resistance.<\/jats:p>","DOI":"10.1007\/s00018-026-06171-8","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T01:15:33Z","timestamp":1776820533000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Game of clones: decipher lineage plasticity in hormone-driven cancers"],"prefix":"10.1007","volume":"83","author":[{"given":"Amanda","family":"Leonita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Warrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac Yi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0955-0896","authenticated-orcid":false,"given":"Ping","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"issue":"4","key":"6171_CR1","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1158\/0008-5472.CAN-04-2688","volume":"65","author":"E Asatiani","year":"2005","unstructured":"Asatiani E, Huang W-X, Wang A, Rodriguez Ortner E, Cavalli LR, Haddad BR, Gelmann EP (2005) Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer. Cancer Res 65(4):1164\u20131173. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-2688","journal-title":"Cancer Res"},{"issue":"5","key":"6171_CR2","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.ccell.2019.04.012","volume":"35","author":"MA Augello","year":"2019","unstructured":"Augello MA, Liu D, Deonarine LD, Robinson BD, Huang D, Stelloo S, Blattner M, Doane AS, Wong EWP, Chen Y, Rubin MA, Beltran H, Elemento O, Bergman AM, Zwart W, Sboner A, Dephoure N, Barbieri CE (2019) CHD1 loss alters AR binding at lineage-specific enhancers and modulates distinct transcriptional programs to drive prostate tumorigenesis. Cancer Cell 35(5):817\u2013819. https:\/\/doi.org\/10.1016\/j.ccell.2019.04.012","journal-title":"Cancer Cell"},{"key":"6171_CR3","doi-asserted-by":"publisher","DOI":"10.1101\/2025.06.25.661532","author":"\u017d Avsec","year":"2025","unstructured":"Avsec \u017d, Latysheva N, Cheng J, Novati G, Taylor KR, Ward T, Bycroft C, Nicolaisen L, Arvaniti E, Pan J, Thomas R, Dutordoir V, Perino M, De S, Karollus A, Gayoso A, Sargeant T, Mottram A, Wong LH, Kohli P (2025) AlphaGenome: advancing regulatory variant effect prediction with a unified DNA sequence model. bioRxiv. https:\/\/doi.org\/10.1101\/2025.06.25.661532","journal-title":"bioRxiv"},{"issue":"1","key":"6171_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22139-7","volume":"12","author":"SC Baca","year":"2021","unstructured":"Baca SC, Takeda DY, Seo J-H, Hwang J, Ku SY, Arafeh R, Arnoff T, Agarwal S, Bell C, O\u2019Connor E, Qiu X, Alaiwi SA, Corona RI, Fonseca MAS, Giambartolomei C, Cejas P, Lim K, He M, Sheahan A, Nassar A, Berchuck JE, Brown L, Nguyen HM, Coleman IM, Kaipainen A, De Sarkar N, Nelson PS, Morrissey C, Korthauer K, Pomerantz MM, Ellis L, Pasaniuc B, Lawrenson K, Kelly K, Zoubeidi A, Hahn WC, Beltran H, Long HW, Brown M, Corey E, Freedman ML (2021) Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer. Nat Commun 12(1):1979. https:\/\/doi.org\/10.1038\/s41467-021-22139-7","journal-title":"Nat Commun"},{"issue":"15","key":"6171_CR5","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1158\/1078-0432.CCR-07-0122","volume":"13","author":"S Badve","year":"2007","unstructured":"Badve S, Turbin D, Thorat MA, Morimiya A, Nielsen TO, Perou CM, Dunn S, Huntsman DG, Nakshatri H (2007) FOXA1 expression in breast cancer\u2014correlation with luminal subtype A and survival. Clin Cancer Res 13(15):4415\u20134421. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-0122","journal-title":"Clin Cancer Res"},{"issue":"3","key":"6171_CR6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/cr.2011.22","volume":"21","author":"AJ Bannister","year":"2011","unstructured":"Bannister AJ, Kouzarides T (2011) Regulation of chromatin by histone modifications. Cell Res 21(3):381\u2013395. https:\/\/doi.org\/10.1038\/cr.2011.22","journal-title":"Cell Res"},{"issue":"3","key":"6171_CR7","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nm.4045","volume":"22","author":"H Beltran","year":"2016","unstructured":"Beltran H, Prandi D, Mosquera JM, Benelli M, Puca L, Cyrta J, Marotz C, Giannopoulou E, Chakravarthi BVSK, Varambally S, Tomlins SA, Nanus DM, Tagawa ST, Van Allen EM, Elemento O, Sboner A, Garraway LA, Rubin MA, Demichelis F (2016) Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. Nat Med 22(3):298\u2013305. https:\/\/doi.org\/10.1038\/nm.4045","journal-title":"Nat Med"},{"issue":"9","key":"6171_CR8","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1172\/JCI127961","volume":"129","author":"A Berger","year":"2019","unstructured":"Berger A, Brady NJ, Bareja R, Robinson B, Conteduca V, Augello MA, Puca L, Ahmed A, Dardenne E, Lu X, Hwang I, Bagadion AM, Sboner A, Elemento O, Paik J, Yu J, Barbieri CE, Dephoure N, Beltran H, Rickman DS (2019) N-Myc\u2013mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer. J Clin Invest 129(9):3924\u20133940. https:\/\/doi.org\/10.1172\/JCI127961","journal-title":"J Clin Invest"},{"issue":"5","key":"6171_CR9","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/onc.2012.62","volume":"32","author":"GM Bernardo","year":"2013","unstructured":"Bernardo GM, Bebek G, Ginther CL, Sizemore ST, Lozada KL, Miedler JD, Anderson LA, Godwin AK, Abdul-Karim FW, Slamon DJ, Keri RA (2013) FOXA1 represses the molecular phenotype of basal breast cancer cells. Oncogene 32(5):554\u2013563. https:\/\/doi.org\/10.1038\/onc.2012.62","journal-title":"Oncogene"},{"issue":"3","key":"6171_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100219","volume":"2","author":"P Bhat-Nakshatri","year":"2021","unstructured":"Bhat-Nakshatri P, Gao H, Sheng L, McGuire PC, Xuei X, Wan J, Liu Y, Althouse SK, Colter A, Sandusky G, Storniolo AM, Nakshatri H (2021) A single-cell atlas of the healthy breast tissues reveals clinically relevant clusters of breast epithelial cells. Cell Rep Med 2(3):100219. https:\/\/doi.org\/10.1016\/j.xcrm.2021.100219","journal-title":"Cell Rep Med"},{"issue":"8","key":"6171_CR11","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1101\/gad.13.8.966","volume":"13","author":"R Bhatia-Gaur","year":"1999","unstructured":"Bhatia-Gaur R, Donjacour AA, Sciavolino PJ, Kim M, Desai N, Young P, Norton CR, Gridley T, Cardiff RD, Cunha GR, Abate-Shen C, Shen MM (1999) Roles for Nkx3.1 in prostate development and cancer. Genes Dev 13(8):966\u2013977. https:\/\/doi.org\/10.1101\/gad.13.8.966","journal-title":"Genes Dev"},{"issue":"6","key":"6171_CR12","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41556-020-0514-z","volume":"22","author":"M Bi","year":"2020","unstructured":"Bi M, Zhang Z, Jiang Y-Z, Xue P, Wang H, Lai Z, Fu X, De Angelis C, Gong Y, Gao Z, Ruan J, Jin VX, Marangoni E, Montaudon E, Glass CK, Li W, Huang T-M, Shao Z-M, Schiff R, Chen L, Liu Z (2020a) Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance. Nat Cell Biol 22(6):701\u2013715. https:\/\/doi.org\/10.1038\/s41556-020-0514-z","journal-title":"Nat Cell Biol"},{"key":"6171_CR13","doi-asserted-by":"publisher","unstructured":"Bi M, Zhang Z, Jiang Y-Z, Xue P, Wang H, Lai Z, Fu X, De Angelis C, Gong Y, Gao Z, Ruan J, Jin VX, Marangoni E, Montaudon E, Glass CK, Li W, Huang TH-M, Shao Z-M, Schiff R, Chen L, Liu Z (2020) Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance. Nat Cell Biol 22(6):701\u2013715. https:\/\/doi.org\/10.1038\/s41556-020-0514-z","DOI":"10.1038\/s41556-020-0514-z"},{"issue":"1","key":"6171_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1158\/2159-8290.CD-15-1263","volume":"7","author":"JL Bishop","year":"2017","unstructured":"Bishop JL, Thaper D, Vahid S, Davies A, Ketola K, Kuruma H, Jama R, Nip KM, Angeles A, Johnson F, Wyatt AW, Fazli L, Gleave ME, Lin D, Rubin MA, Collins CC, Wang Y, Beltran H, Zoubeidi A (2017) The master neural transcription factor BRN2 is an androgen receptor\u2013suppressed driver of neuroendocrine differentiation in prostate cancer. Cancer Discov 7(1):54\u201371. https:\/\/doi.org\/10.1158\/2159-8290.CD-15-1263","journal-title":"Cancer Discov"},{"issue":"2","key":"6171_CR15","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1530\/ERC-20-0272","volume":"28","author":"EB Blatt","year":"2021","unstructured":"Blatt EB, Kopplin N, Kumar S, Mu P, Conzen SD, Raj GV (2021) Overcoming oncogene addiction in breast and prostate cancers: a comparative mechanistic overview. Endocr Relat Cancer 28(2):R31\u2013R46. https:\/\/doi.org\/10.1530\/ERC-20-0272","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"6171_CR16","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ccell.2017.09.003","volume":"32","author":"EG Bluemn","year":"2017","unstructured":"Bluemn EG, Coleman IM, Lucas JM, Coleman RT, Hernandez-Lopez S, Tharakan R, Bianchi-Frias D, Dumpit RF, Kaipainen A, Corella AN, Yang YC, Nyquist MD, Mostaghel E, Hsieh AC, Zhang X, Corey E, Brown LG, Nguyen HM, Pienta K, Ittmann M, Schweizer M, True LD, Wise D, Rennie PS, Vessella RL, Morrissey C, Nelson PS (2017) Androgen receptor pathway-independent prostate cancer is sustained through FGF signaling. Cancer Cell 32(4):474-489.e6. https:\/\/doi.org\/10.1016\/j.ccell.2017.09.003","journal-title":"Cancer Cell"},{"issue":"1","key":"6171_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21615-4","volume":"12","author":"L Brady","year":"2021","unstructured":"Brady L, Kriner M, Coleman I, Morrissey C, Roudier M, True LD, Gulati R, Plymate SR, Zhou Z, Birditt B, Meredith R, Geiss G, Hoang M, Beechem J, Nelson PS (2021) Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling. Nat Commun 12(1):1426. https:\/\/doi.org\/10.1038\/s41467-021-21615-4","journal-title":"Nat Commun"},{"issue":"6611","key":"6171_CR18","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1126\/science.abn0478","volume":"377","author":"JM Chan","year":"2022","unstructured":"Chan JM, Zaidi S, Love JR, Zhao JL, Setty M, Wadosky KM, Gopalan A, Choo ZN, Persad S, Choi J, LaClair J, Lawrence KE, Chaudhary O, Xu T, Masilionis I, Linkov I, Wang S, Lee C, Barlas A, Morris MJ, Sawyers CL (2022) Lineage plasticity in prostate cancer depends on JAK\/STAT inflammatory signaling. Science 377(6611):1180\u20131191. https:\/\/doi.org\/10.1126\/science.abn0478","journal-title":"Science"},{"issue":"1","key":"6171_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-020-00137-0","volume":"4","author":"X Chen","year":"2020","unstructured":"Chen X, Ma Q, Shang Z, Niu Y (2020) Super-enhancer in prostate cancer: transcriptional disorders and therapeutic targets. NPJ Precis Oncol 4(1):31. https:\/\/doi.org\/10.1038\/s41698-020-00137-0","journal-title":"NPJ Precis Oncol"},{"issue":"5","key":"6171_CR20","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/s43018-025-00952-z","volume":"6","author":"F Chen","year":"2025","unstructured":"Chen F, Li H, Wang Y, Tang X, Lin K, Li Q, Meng C, Shi W, Leo J, Liang X, Zhang J, Van V, Mahmud I, Wei B, Lorenzi PL, Raso MG, Aparicio A, Lu Y, Frigo DE, Gan B, Zhao D (2025) CHD1 loss reprograms SREBP2-driven cholesterol synthesis to fuel androgen-responsive growth and castration resistance in SPOP-mutated prostate tumors. Nat Cancer 6(5):854\u2013873. https:\/\/doi.org\/10.1038\/s43018-025-00952-z","journal-title":"Nat Cancer"},{"issue":"1","key":"6171_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00667-x","volume":"8","author":"S Cheng","year":"2024","unstructured":"Cheng S, Li L, Yeh Y, Shi Y, Franco O, Corey E, Yu X (2024) Unveiling novel double-negative prostate cancer subtypes through single-cell RNA sequencing analysis. NPJ Precis Oncol 8(1):171. https:\/\/doi.org\/10.1038\/s41698-024-00667-x","journal-title":"NPJ Precis Oncol"},{"issue":"11","key":"6171_CR22","doi-asserted-by":"publisher","first-page":"4613","DOI":"10.1210\/endo.138.11.5496","volume":"138","author":"JF Couse","year":"1997","unstructured":"Couse JF, Lindzey J, Grandien K, Gustafsson JA, Korach KS (1997) Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology 138(11):4613\u20134621. https:\/\/doi.org\/10.1210\/endo.138.11.5496","journal-title":"Endocrinology"},{"issue":"1","key":"6171_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19328-1","volume":"11","author":"J Cyrta","year":"2020","unstructured":"Cyrta J, Augspach A, De Filippo MR, Prandi D, Thienger P, Benelli M, Cooley V, Bareja R, Wilkes D, Chae SS, Cavaliere P, Dephoure N, Uldry AC, Lagache SB, Roma L, Cohen S, Jaquet M, Brandt LP, Alshalalfa M, Puca L, Sboner A, Feng F, Wang S, Beltran H, Lotan T, Spahn M, de Kruithof- Julio M, Chen Y, Ballman KV, Demichelis F, Piscuoglio S, Rubin MA (2020) Role of specialized composition of SWI\/SNF complexes in prostate cancer lineage plasticity. Nat Commun 11(1):5549. https:\/\/doi.org\/10.1038\/s41467-020-19328-1","journal-title":"Nat Commun"},{"issue":"9","key":"6171_CR24","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/s43018-022-00431-9","volume":"3","author":"S Deng","year":"2022","unstructured":"Deng S, Wang C, Wang Y, Xu Y, Li X, Johnson NA, Mukherji A, Lo UG, Xu L, Gonzalez J, Metang LA, Ye J, Tirado CR, Rodarte K, Zhou Y, Xie Z, Arana C, Annamalai V, Liu X, Vander Griend DJ, Strand D, Hsieh J-T, Li B, Raj G, Wang T, Mu P (2022) Ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance. Nat Cancer 3(9):1071\u20131087. https:\/\/doi.org\/10.1038\/s43018-022-00431-9","journal-title":"Nat Cancer"},{"issue":"488","key":"6171_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aav0936","volume":"11","author":"GV Echeverria","year":"2019","unstructured":"Echeverria GV, Ge Z, Seth S, Zhang X, Jeter-Jones S, Zhou X, Cai S, Tu Y, McCoy A, Peoples M, Sun Y, Qiu H, Chang Q, Bristow C, Carugo A, Shao J, Ma X, Harris A, Mundi P, Lau R, Piwnica-Worms H (2019) Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state. Sci Transl Med 11(488):eaav0936. https:\/\/doi.org\/10.1126\/scitranslmed.aav0936","journal-title":"Sci Transl Med"},{"issue":"10","key":"6171_CR26","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/ncb2581","volume":"14","author":"JH van Es","year":"2012","unstructured":"van Es JH, Sato T, van de Wetering M, Lyubimova A, Yee Nee AN, Gregorieff A, Sasaki N, Zeinstra L, van den Born M, Korving J, Martens ACM, Barker N, van Oudenaarden A, Clevers H (2012) Dll1+ secretory progenitor cells revert to stem cells upon crypt damage. Nat Cell Biol 14(10):1099\u20131104. https:\/\/doi.org\/10.1038\/ncb2581","journal-title":"Nat Cell Biol"},{"key":"6171_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215901","volume":"548","author":"AM Ferguson","year":"2022","unstructured":"Ferguson AM, Rubin MA (2022) Lineage plasticity in prostate cancer: looking beyond intrinsic alterations. Cancer Lett 548:215901. https:\/\/doi.org\/10.1016\/j.canlet.2022.215901","journal-title":"Cancer Lett"},{"issue":"6348","key":"6171_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/science.aal2380","volume":"357","author":"WA Flavahan","year":"2017","unstructured":"Flavahan WA, Gaskell E, Bernstein BE (2017) Epigenetic plasticity and the hallmarks of cancer. Science 357(6348):eaal2380. https:\/\/doi.org\/10.1126\/science.aal2380","journal-title":"Science"},{"issue":"1","key":"6171_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00510-x","volume":"8","author":"T Fleischer","year":"2017","unstructured":"Fleischer T, Tekpli X, Mathelier A, Wang S, Nebdal D, Dhakal HP, Sahlberg KK, Schlichting E, B\u00f8rresen-Dale A-L, Borgen E, Naume B, Eskeland R, Frigessi A, Tost J, Hurtado A, Kristensen VN (2017) DNA methylation at enhancers identifies distinct breast cancer lineages. Nat Commun 8(1):1379. https:\/\/doi.org\/10.1038\/s41467-017-00510-x","journal-title":"Nat Commun"},{"issue":"8","key":"6171_CR30","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1210\/me.2003-0020","volume":"17","author":"N Gao","year":"2003","unstructured":"Gao N, Zhang J, Rao MA, Case TC, Mirosevich J, Wang Y, Jin R, Gupta A, Rennie PS, Matusik RJ (2003) The role of hepatocyte nuclear factor-3 alpha (Forkhead Box A1) and androgen receptor in transcriptional regulation of prostatic genes. Molecular endocrinology (Baltimore, Md) 17(8):1484\u20131507. https:\/\/doi.org\/10.1210\/me.2003-0020","journal-title":"Molecular endocrinology (Baltimore, Md)"},{"issue":"11","key":"6171_CR31","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/s41594-022-00856-x","volume":"29","author":"L Garcia-Martinez","year":"2022","unstructured":"Garcia-Martinez L, Adams AM, Chan HL, Nakata Y, Weich N, Stransky S, Zhang Z, Alshalalfa M, Sarria L, Mahal BA, Kesmodel SB, Celi\u00e0-Terrassa T, Liu Z, Minucci S, Bilbao D, Sidoli S, Verdun RE, Morey L (2022) Endocrine resistance and breast cancer plasticity are controlled by CoREST. Nat Struct Mol Biol 29(11):1122\u20131135. https:\/\/doi.org\/10.1038\/s41594-022-00856-x","journal-title":"Nat Struct Mol Biol"},{"issue":"5","key":"6171_CR32","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S0896-6273(03)00497-5","volume":"39","author":"V Graham","year":"2003","unstructured":"Graham V, Khudyakov J, Ellis P, Pevny L (2003) SOX2 functions to maintain neural progenitor identity. Neuron 39(5):749\u2013765. https:\/\/doi.org\/10.1016\/S0896-6273(03)00497-5","journal-title":"Neuron"},{"key":"6171_CR33","doi-asserted-by":"publisher","unstructured":"Granja JM, Corces MR, Pierce SE, Bagdatli ST, Choudhry H, Chang HY, Greenleaf WJ (2021) ArchR is a scalable software package for integrative single-cell chromatin accessibility analysis. Nature genetics 53(3):403\u2013411. https:\/\/doi.org\/10.1038\/s41588-021-00790-6","DOI":"10.1038\/s41588-021-00790-6"},{"issue":"1","key":"6171_CR34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1083\/jcb.95.1.333","volume":"95","author":"G Greenburg","year":"1982","unstructured":"Greenburg G, Hay ED (1982) Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells. J Cell Biol 95(1):333\u2013339. https:\/\/doi.org\/10.1083\/jcb.95.1.333","journal-title":"J Cell Biol"},{"issue":"5","key":"6171_CR35","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.cell.2012.02.008","volume":"148","author":"W Guo","year":"2012","unstructured":"Guo W, Keckesova Z, Donaher JL, Shibue T, Tischler V, Reinhardt F, Itzkovitz S, Noske A, Z\u00fcrrer-H\u00e4rdi U, Bell G, Tam WL, Mani SA, van Oudenaarden A, Weinberg RA (2012) Slug and Sox9 cooperatively determine the mammary stem cell state. Cell 148(5):1015\u20131028. https:\/\/doi.org\/10.1016\/j.cell.2012.02.008","journal-title":"Cell"},{"issue":"4","key":"6171_CR36","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.cell.2011.07.026","volume":"146","author":"PB Gupta","year":"2011","unstructured":"Gupta PB, Fillmore CM, Jiang G, Shapira SD, Tao K, Kuperwasser C, Lander ES (2011) Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 146(4):633\u2013644. https:\/\/doi.org\/10.1016\/j.cell.2011.07.026","journal-title":"Cell"},{"issue":"10","key":"6171_CR37","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nmeth.3971","volume":"13","author":"L Haghverdi","year":"2016","unstructured":"Haghverdi L, B\u00fcttner M, Wolf FA, Buettner F, Theis FJ (2016) Diffusion pseudotime robustly reconstructs lineage branching. Nat Methods 13(10):845\u2013848. https:\/\/doi.org\/10.1038\/nmeth.3971","journal-title":"Nat Methods"},{"issue":"1","key":"6171_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D (2022) Hallmarks of cancer: new dimensions. Cancer Discov 12(1):31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1059","journal-title":"Cancer Discov"},{"key":"6171_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2025.12.049","author":"D Hanahan","year":"2026","unstructured":"Hanahan D (2026) Hallmarks of cancer-then and now, and beyond. Cell. https:\/\/doi.org\/10.1016\/j.cell.2025.12.049","journal-title":"Cell"},{"issue":"1","key":"6171_CR40","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41574-022-00742-y","volume":"19","author":"FM Hannan","year":"2023","unstructured":"Hannan FM, Elajnaf T, Vandenberg LN, Kennedy SH, Thakker RV (2023) Hormonal regulation of mammary gland development and lactation. Nat Rev Endocrinol 19(1):46\u201361. https:\/\/doi.org\/10.1038\/s41574-022-00742-y","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"6171_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36325-2","volume":"14","author":"T Hirz","year":"2023","unstructured":"Hirz T, Mei S, Sarkar H, Kfoury Y, Wu S, Verhoeven BM, Subtelny AO, Zlatev DV, Wszolek MW, Salari K, Murray E, Chen F, Macosko EZ, Wu C-L, Scadden DT, Dahl DM, Baryawno N, Saylor PJ, Kharchenko PV, Sykes DB (2023) Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses. Nat Commun 14(1):663. https:\/\/doi.org\/10.1038\/s41467-023-36325-2","journal-title":"Nat Commun"},{"issue":"6","key":"6171_CR42","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nrg3209","volume":"13","author":"J Holmberg","year":"2012","unstructured":"Holmberg J, Perlmann T (2012) Maintaining differentiated cellular identity. Nat Rev Genet 13(6):429\u2013439. https:\/\/doi.org\/10.1038\/nrg3209","journal-title":"Nat Rev Genet"},{"issue":"1","key":"6171_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03279-9","volume":"9","author":"J Huang","year":"2018","unstructured":"Huang J, Li K, Cai W, Liu X, Zhang Y, Orkin SH, Xu J, Yuan G-C (2018) Dissecting super-enhancer hierarchy based on chromatin interactions. Nat Commun 9(1):943. https:\/\/doi.org\/10.1038\/s41467-018-03279-9","journal-title":"Nat Commun"},{"issue":"9","key":"6171_CR44","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1038\/s43018-025-00994-3","volume":"6","author":"C Jiang","year":"2025","unstructured":"Jiang C, Song Y, Rorive S, Allard J, Tika E, Zahedi Z, Dubois C, Salmon I, Sifrim A, Blanpain C (2025) Innate immunity and the NF-\u03baB pathway control prostate stem cell plasticity, reprogramming and tumor initiation. Nat Cancer 6(9):1537\u20131558. https:\/\/doi.org\/10.1038\/s43018-025-00994-3","journal-title":"Nat Cancer"},{"issue":"1","key":"6171_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06052-0","volume":"9","author":"M Karaayvaz","year":"2018","unstructured":"Karaayvaz M, Cristea S, Gillespie SM, Patel AP, Mylvaganam R, Luo CC, Specht MC, Bernstein BE, Michor F, Ellisen LW (2018) Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq. Nat Commun 9(1):3588. https:\/\/doi.org\/10.1038\/s41467-018-06052-0","journal-title":"Nat Commun"},{"issue":"6490","key":"6171_CR46","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1126\/science.aay0267","volume":"368","author":"WR Karthaus","year":"2020","unstructured":"Karthaus WR, Hofree M, Choi D, Linton EL, Turkekul M, Bejnood A, Carver B, Gopalan A, Abida W, Laudone V, Biton M, Chaudhary O, Xu T, Masilionis I, Manova K, Mazutis L, Pe\u2019er D, Regev A, Sawyers CL (2020) Regenerative potential of prostate luminal cells revealed by single-cell analysis. Science 368(6490):497\u2013505. https:\/\/doi.org\/10.1126\/science.aay0267","journal-title":"Science"},{"issue":"1","key":"6171_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09982-5","volume":"10","author":"HS Kaya-Okur","year":"2019","unstructured":"Kaya-Okur HS, Wu SJ, Codomo CA, Pledger ES, Bryson TD, Henikoff JG, Ahmad K, Henikoff S (2019) CUT&tag for efficient epigenomic profiling of small samples and single cells. Nat Commun 10(1):1930. https:\/\/doi.org\/10.1038\/s41467-019-09982-5","journal-title":"Nat Commun"},{"issue":"3","key":"6171_CR48","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1080\/15592294.2016.1146851","volume":"11","author":"B Kleb","year":"2016","unstructured":"Kleb B, Est\u00e9cio MRH, Zhang J, Tzelepi V, Chung W, Jelinek J, Navone NM, Tahir S, Marquez VE, Issa J-P, Maity S, Aparicio A (2016) Differentially methylated genes and androgen receptor re-expression in small cell prostate carcinomas. Epigenetics 11(3):184\u2013193. https:\/\/doi.org\/10.1080\/15592294.2016.1146851","journal-title":"Epigenetics"},{"issue":"4","key":"6171_CR49","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.molcel.2015.10.031","volume":"60","author":"S Koren","year":"2015","unstructured":"Koren S, Bentires-Alj M (2015) Breast tumor heterogeneity: source of fitness, hurdle for therapy. Mol Cell 60(4):537\u2013546. https:\/\/doi.org\/10.1016\/j.molcel.2015.10.031","journal-title":"Mol Cell"},{"issue":"15","key":"6171_CR50","doi-asserted-by":"publisher","first-page":"7353","DOI":"10.1073\/pnas.1812876116","volume":"116","author":"C Kr\u00f6ger","year":"2019","unstructured":"Kr\u00f6ger C, Afeyan A, Mraz J, Eaton EN, Reinhardt F, Khodor YL, Thiru P, Bierie B, Ye X, Burge CB, Weinberg RA (2019) Acquisition of a hybrid E\/M state is essential for tumorigenicity of basal breast cancer cells. Proc Natl Acad Sci USA 116(15):7353\u20137362. https:\/\/doi.org\/10.1073\/pnas.1812876116","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6320","key":"6171_CR51","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1126\/science.aah4199","volume":"355","author":"SY Ku","year":"2017","unstructured":"Ku SY, Rosario S, Wang Y, Mu P, Seshadri M, Goodrich ZW, Goodrich MM, Labb\u00e9 DP, Gomez EC, Wang J, Long HW, Xu B, Brown M, Loda M, Sawyers CL, Ellis L, Goodrich DW (2017) Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance. Science 355(6320):78\u201383. https:\/\/doi.org\/10.1126\/science.aah4199","journal-title":"Science"},{"key":"6171_CR52","doi-asserted-by":"crossref","unstructured":"Kwon OJ, Zhang L, Jia D, Xin L (2021) Sox2 is necessary for androgen ablation-induced neuroendocrine differentiation from Pten null Sca-1+ prostate luminal cells","DOI":"10.1038\/s41388-020-01526-2"},{"issue":"7719","key":"6171_CR53","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41586-018-0414-6","volume":"560","author":"G La Manno","year":"2018","unstructured":"La Manno G, Soldatov R, Zeisel A, Braun E, Hochgerner H, Petukhov V, Lidschreiber K, Kastriti ME, L\u00f6nnerberg P, Furlan A, Fan J, Borm LE, Liu Z, van Bruggen D, Guo J, He X, Barker R, Sundstr\u00f6m E, Castelo-Branco G, Kharchenko PV (2018) RNA velocity of single cells. Nature 560(7719):494\u2013498. https:\/\/doi.org\/10.1038\/s41586-018-0414-6","journal-title":"Nature"},{"issue":"4","key":"6171_CR54","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ccell.2016.03.001","volume":"29","author":"JK Lee","year":"2016","unstructured":"Lee JK, Phillips JW, Smith BA, Park JW, Stoyanova T, McCaffrey EF, Baertsch R, Sokolov A, Meyerowitz JG, Mathis C, Cheng D, Stuart JM, Shokat KM, Gustafson WC, Huang J, Witte ON (2016) N-Myc drives neuroendocrine prostate cancer initiated from human prostate epithelial cells. Cancer Cell 29(4):536\u2013547. https:\/\/doi.org\/10.1016\/j.ccell.2016.03.001","journal-title":"Cancer Cell"},{"issue":"7","key":"6171_CR55","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1172\/JCI45014","volume":"121","author":"BD Lehmann","year":"2011","unstructured":"Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA (2011) Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest 121(7):2750\u20132767. https:\/\/doi.org\/10.1172\/JCI45014","journal-title":"J Clin Invest"},{"key":"6171_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1123362","volume":"13","author":"H Li","year":"2023","unstructured":"Li H, Gigi L, Zhao D (2023) CHD1, a multifaceted epigenetic remodeler in prostate cancer. Front Oncol 13:1123362. https:\/\/doi.org\/10.3389\/fonc.2023.1123362","journal-title":"Front Oncol"},{"issue":"8","key":"6171_CR57","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.ccell.2023.06.010","volume":"41","author":"X Li","year":"2023","unstructured":"Li X, Wang Y, Deng S, Zhu G, Wang C, Johnson NA, Zhang Z, Tirado CR, Xu Y, Metang LA, Gonzalez J, Mukherji A, Ye J, Yang Y, Peng W, Tang Y, Hofstad M, Xie Z, Yoon H, Chen L, Mu P (2023) Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer. Cancer Cell 41(8):1427-1449.e12. https:\/\/doi.org\/10.1016\/j.ccell.2023.06.010","journal-title":"Cancer Cell"},{"issue":"11","key":"6171_CR58","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/s41422-025-01180-x","volume":"35","author":"X Li","year":"2025","unstructured":"Li X, Gardner EE, Molina-Pinelo S, Wilhelm C, Mu P, Quintanal-Villalonga \u00c1 (2025) Lineage plasticity and histological transformation: tumor histology as a spectrum. Cell Res 35(11):803\u2013823. https:\/\/doi.org\/10.1038\/s41422-025-01180-x","journal-title":"Cell Res"},{"issue":"1","key":"6171_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02595-6","volume":"23","author":"G Li","year":"2022","unstructured":"Li G, Fu S, Wang S, Zhu C, Duan B, Tang C, Chen X, Chuai G, Wang P, Liu Q (2022) A deep generative model for multi-view profiling of single-cell RNA-seq and ATAC-seq data. Genome Biol 23(1):20. https:\/\/doi.org\/10.1186\/s13059-021-02595-6","journal-title":"Genome Biol"},{"issue":"1","key":"6171_CR60","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.stemcr.2013.11.009","volume":"2","author":"S Liu","year":"2014","unstructured":"Liu S, Cong Y, Wang D, Sun Y, Deng L, Liu Y, Martin-Trevino R, Shang L, McDermott SP, Landis MD, Hong S, Adams A, D\u2019Angelo R, Ginestier C, Charafe-Jauffret E, Clouthier SG, Birnbaum D, Wong ST, Zhan M, Wicha MS (2014) Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts. Stem Cell Reports 2(1):78\u201391. https:\/\/doi.org\/10.1016\/j.stemcr.2013.11.009","journal-title":"Stem Cell Reports"},{"issue":"8","key":"6171_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.978","volume":"12","author":"UG Lo","year":"2022","unstructured":"Lo UG, Chen YA, Cen J, Deng S, Luo J, Zhau H, Ho L, Lai CH, Mu P, Chung LWK, Hsieh JT (2022) The driver role of JAK-STAT signalling in cancer stemness capabilities leading to new therapeutic strategies for therapy- and castration-resistant prostate cancer. Clin Transl Med 12(8):e978. https:\/\/doi.org\/10.1002\/ctm2.978","journal-title":"Clin Transl Med"},{"issue":"10","key":"6171_CR62","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41576-021-00370-8","volume":"22","author":"SK Longo","year":"2021","unstructured":"Longo SK, Guo MG, Ji AL, Khavari PA (2021) Integrating single-cell and spatial transcriptomics to elucidate intercellular tissue dynamics. Nat Rev Genet 22(10):627\u2013644. https:\/\/doi.org\/10.1038\/s41576-021-00370-8","journal-title":"Nat Rev Genet"},{"issue":"12","key":"6171_CR63","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/s41592-018-0229-2","volume":"15","author":"R Lopez","year":"2018","unstructured":"Lopez R, Regier J, Cole MB, Jordan MI, Yosef N (2018) Deep generative modeling for single-cell transcriptomics. Nat Methods 15(12):1053\u20131058. https:\/\/doi.org\/10.1038\/s41592-018-0229-2","journal-title":"Nat Methods"},{"issue":"8","key":"6171_CR64","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41592-019-0494-8","volume":"16","author":"M Lotfollahi","year":"2019","unstructured":"Lotfollahi M, Wolf FA, Theis FJ (2019) Scgen predicts single-cell perturbation responses. Nat Methods 16(8):715\u2013721. https:\/\/doi.org\/10.1038\/s41592-019-0494-8","journal-title":"Nat Methods"},{"issue":"8","key":"6171_CR65","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1038\/s41588-025-02265-4","volume":"57","author":"X Lu","year":"2025","unstructured":"Lu X, Keo V, Cheng I, Xie W, Gritsina G, Wang J, Lu L, Shiau C-K, He Y, Jin Q, Jin P, Sanda MG, Corces VG, Altemose N, Gao R, Zhao JC, Yu J (2025) NKX2-1 drives neuroendocrine transdifferentiation of prostate cancer via epigenetic and 3D chromatin remodeling. Nat Genet 57(8):1966\u20131980. https:\/\/doi.org\/10.1038\/s41588-025-02265-4","journal-title":"Nat Genet"},{"issue":"2","key":"6171_CR66","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1677\/ERC-09-0038","volume":"16","author":"M Lupien","year":"2009","unstructured":"Lupien M, Brown M (2009) Cistromics of hormone-dependent cancer. Endocr Relat Cancer 16(2):381\u2013389. https:\/\/doi.org\/10.1677\/ERC-09-0038","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"6171_CR67","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.cell.2008.01.018","volume":"132","author":"M Lupien","year":"2008","unstructured":"Lupien M, Eeckhoute J, Meyer CA, Wang Q, Zhang Y, Li W, Carroll JS, Liu XS, Brown M (2008) FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 132(6):958\u2013970. https:\/\/doi.org\/10.1016\/j.cell.2008.01.018","journal-title":"Cell"},{"key":"6171_CR68","doi-asserted-by":"publisher","unstructured":"Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery CA Jr, Shyamala G, Conneely OM, O\u2019Malley BW (1995) Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 9(18):2266\u20132278. https:\/\/doi.org\/10.1101\/gad.9.18.2266","DOI":"10.1101\/gad.9.18.2266"},{"issue":"1","key":"6171_CR69","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1146\/annurev-cancerbio-030617-050224","volume":"2","author":"CL Magnen","year":"2018","unstructured":"Magnen CL, Shen MM, Abate-Shen C (2018) Lineage plasticity in cancer progression and treatment. Annu Rev Cancer Biol 2(1):271\u2013289. https:\/\/doi.org\/10.1146\/annurev-cancerbio-030617-050224","journal-title":"Annu Rev Cancer Biol"},{"issue":"12","key":"6171_CR70","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41568-020-00302-4","volume":"20","author":"J-C Marine","year":"2020","unstructured":"Marine J-C, Dawson S-J, Dawson MA (2020) Non-genetic mechanisms of therapeutic resistance in cancer. Nat Rev Cancer 20(12):743\u2013756. https:\/\/doi.org\/10.1038\/s41568-020-00302-4","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"6171_CR71","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41588-022-01047-6","volume":"54","author":"J Marsolier","year":"2022","unstructured":"Marsolier J, Prompsy P, Durand A, Lyne AM, Landragin C, Trouchet A, Bento ST, Eisele A, Foulon S, Baudre L, Grosselin K, Bohec M, Baulande S, Dahmani A, Sourd L, Letouz\u00e9 E, Salomon AV, Marangoni E, Peri\u00e9 L, Vallot C (2022) H3K27me3 conditions chemotolerance in triple-negative breast cancer. Nat Genet 54(4):459\u2013468. https:\/\/doi.org\/10.1038\/s41588-022-01047-6","journal-title":"Nat Genet"},{"issue":"6320","key":"6171_CR72","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.aah4307","volume":"355","author":"P Mu","year":"2017","unstructured":"Mu P, Zhang Z, Benelli M, Karthaus WR, Hoover E, Chen C-C, Wongvipat J, Ku S-Y, Gao D, Cao Z, Shah N, Adams EJ, Abida W, Watson PA, Prandi D, Huang C-H, de Stanchina E, Lowe SW, Ellis L, Sawyers CL (2017) SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer. Science 355(6320):84\u201388. https:\/\/doi.org\/10.1126\/science.aah4307","journal-title":"Science"},{"issue":"11","key":"6171_CR73","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/nmeth.3999","volume":"13","author":"MR Mumbach","year":"2016","unstructured":"Mumbach MR, Rubin AJ, Flynn RA, Dai C, Khavari PA, Greenleaf WJ, Chang HY (2016) HiChIP: efficient and sensitive analysis of protein-directed genome architecture. Nat Methods 13(11):919\u2013922. https:\/\/doi.org\/10.1038\/nmeth.3999","journal-title":"Nat Methods"},{"issue":"1","key":"6171_CR74","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41576-020-0265-5","volume":"22","author":"AS Nam","year":"2021","unstructured":"Nam AS, Chaligne R, Landau DA (2021) Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics. Nat Rev Genet 22(1):3\u201318. https:\/\/doi.org\/10.1038\/s41576-020-0265-5","journal-title":"Nat Rev Genet"},{"issue":"1","key":"6171_CR75","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto MA, Huang RY-J, Jackson RA, Thiery JP (2016) EMT: 2016. Cell 166(1):21\u201345. https:\/\/doi.org\/10.1016\/j.cell.2016.06.028","journal-title":"Cell"},{"issue":"1","key":"6171_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29963-5","volume":"13","author":"S Nouruzi","year":"2022","unstructured":"Nouruzi S, Ganguli D, Tabrizian N, Kobelev M, Sivak O, Namekawa T, Thaper D, Baca SC, Freedman ML, Aguda A, Davies A, Zoubeidi A (2022) ASCL1 activates neuronal stem cell-like lineage programming through remodeling of the chromatin landscape in prostate cancer. Nat Commun 13(1):2282. https:\/\/doi.org\/10.1038\/s41467-022-29963-5","journal-title":"Nat Commun"},{"issue":"2","key":"6171_CR77","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41576-022-00532-2","volume":"24","author":"G Novakovsky","year":"2023","unstructured":"Novakovsky G, Dexter N, Libbrecht MW, Wasserman WW, Mostafavi S (2023) Obtaining genetics insights from deep learning via explainable artificial intelligence. Nat Rev Genet 24(2):125\u2013137. https:\/\/doi.org\/10.1038\/s41576-022-00532-2","journal-title":"Nat Rev Genet"},{"issue":"19","key":"6171_CR78","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","volume":"377","author":"H Pan","year":"2017","unstructured":"Pan H, Gray R, Braybrooke J, Davies C, Taylor C, McGale P, Peto R, Pritchard KI, Bergh J, Dowsett M, Hayes DF (2017) 20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years. N Engl J Med 377(19):1836\u20131846. https:\/\/doi.org\/10.1056\/NEJMoa1701830","journal-title":"N Engl J Med"},{"issue":"7702","key":"6171_CR79","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-018-0040-3","volume":"556","author":"I Pastushenko","year":"2018","unstructured":"Pastushenko I, Brisebarre A, Sifrim A, Fioramonti M, Revenco T, Boumahdi S, Van Keymeulen A, Brown D, Moers V, Lemaire S, De Clercq S, Minguij\u00f3n E, Balsat C, Sokolow Y, Dubois C, De Cock F, Scozzaro S, Sopena F, Lanas A, Blanpain C (2018) Identification of the tumour transition states occurring during EMT. Nature 556(7702):463\u2013468. https:\/\/doi.org\/10.1038\/s41586-018-0040-3","journal-title":"Nature"},{"key":"6171_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-023-00523-4","volume":"9","author":"R Patel","year":"2023","unstructured":"Patel R, Klein P, Tiersten A, Sparano JA (2023) An emerging generation of endocrine therapies in breast cancer: a clinical perspective. NPJ Breast Cancer 9:20. https:\/\/doi.org\/10.1038\/s41523-023-00523-4","journal-title":"NPJ Breast Cancer"},{"issue":"11","key":"6171_CR81","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1038\/ng.3419","volume":"47","author":"MM Pomerantz","year":"2015","unstructured":"Pomerantz MM, Li F, Takeda DY, Lenci R, Chonkar A, Chabot M, Cejas P, Vazquez F, Cook J, Shivdasani RA, Bowden M, Lis R, Hahn WC, Kantoff PW, Brown M, Loda M, Long HW, Freedman ML (2015) The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis. Nat Genet 47(11):1346\u20131351. https:\/\/doi.org\/10.1038\/ng.3419","journal-title":"Nat Genet"},{"issue":"10","key":"6171_CR82","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.tcb.2024.01.006","volume":"34","author":"X Qin","year":"2024","unstructured":"Qin X, Tape CJ (2024) Functional analysis of cell plasticity using single-cell technologies. Trends Cell Biol 34(10):854\u2013864. https:\/\/doi.org\/10.1016\/j.tcb.2024.01.006","journal-title":"Trends Cell Biol"},{"issue":"5","key":"6171_CR83","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","volume":"161","author":"D Robinson","year":"2015","unstructured":"Robinson D, Van Allen EM, Wu Y-M, Schultz N, Lonigro RJ, Mosquera J-M, Montgomery B, Taplin M-E, Pritchard CC, Attard G, Beltran H, Abida W, Bradley RK, Vinson J, Cao X, Vats P, Kunju LP, Hussain M, Feng FY, Chinnaiyan AM (2015) Integrative clinical genomics of advanced prostate cancer. Cell 161(5):1215\u20131228. https:\/\/doi.org\/10.1016\/j.cell.2015.05.001","journal-title":"Cell"},{"issue":"4","key":"6171_CR84","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41388-023-02890-5","volume":"43","author":"C Rodriguez Tirado","year":"2024","unstructured":"Rodriguez Tirado C, Wang C, Li X, Deng S, Gonzalez J, Johnson NA, Mu P (2024) UBE2J1 is the E2 ubiquitin-conjugating enzyme regulating androgen receptor degradation and antiandrogen resistance. Oncogene 43(4):265\u2013280. https:\/\/doi.org\/10.1038\/s41388-023-02890-5","journal-title":"Oncogene"},{"issue":"11","key":"6171_CR85","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1038\/s43018-024-00838-6","volume":"5","author":"R Romero","year":"2024","unstructured":"Romero R, Chu T, Gonz\u00e1lez Robles TJ, Smith P, Xie Y, Kaur H, Yoder S, Zhao H, Mao C, Kang W, Pulina MV, Lawrence KE, Gopalan A, Zaidi S, Yoo K, Choi J, Fan N, Gerstner O, Karthaus WR, Sawyers CL (2024) The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1. Nat Cancer 5(11):1641\u20131659. https:\/\/doi.org\/10.1038\/s43018-024-00838-6","journal-title":"Nat Cancer"},{"issue":"7381","key":"6171_CR86","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nature10730","volume":"481","author":"CS Ross-Innes","year":"2012","unstructured":"Ross-Innes CS, Stark R, Teschendorff AE, Holmes KA, Ali HR, Dunning MJ, Brown GD, Gojis O, Ellis IO, Green AR, Ali S, Chin S-F, Palmieri C, Caldas C, Carroll JS (2012) Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature 481(7381):389\u2013393. https:\/\/doi.org\/10.1038\/nature10730","journal-title":"Nature"},{"issue":"6400","key":"6171_CR87","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar3958","volume":"361","author":"BR Sabari","year":"2018","unstructured":"Sabari BR, Dall\u2019Agnese A, Boija A, Klein IA, Coffey EL, Shrinivas K, Abraham BJ, Hannett NM, Zamudio AV, Manteiga JC, Li CH, Guo YE, Day DS, Schuijers J, Vasile E, Malik S, Hnisz D, Lee TI, Cisse II, Roeder RG, Sharp PA, Chakraborty AK, Young RA (2018) Coactivator condensation at super-enhancers links phase separation and gene control. Science 361(6400):eaar3958. https:\/\/doi.org\/10.1126\/science.aar3958","journal-title":"Science"},{"issue":"1","key":"6171_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-024-00688-6","volume":"10","author":"J Sandstr\u00f6m","year":"2024","unstructured":"Sandstr\u00f6m J, Bomanson J, P\u00e9rez-Tenorio G, J\u00f6nsson C, Nordenskj\u00f6ld B, Fornander T, Lindstr\u00f6m LS, St\u00e5l O (2024) GATA3 and markers of epithelial-mesenchymal transition predict long-term benefit from tamoxifen in ER-positive breast cancer. NPJ Breast Cancer 10(1):78. https:\/\/doi.org\/10.1038\/s41523-024-00688-6","journal-title":"NPJ Breast Cancer"},{"issue":"2","key":"6171_CR89","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ccell.2019.07.005","volume":"36","author":"N Shah","year":"2019","unstructured":"Shah N, Brown M (2019) The sly oncogene: FOXA1 mutations in prostate cancer. Cancer Cell 36(2):119\u2013121. https:\/\/doi.org\/10.1016\/j.ccell.2019.07.005","journal-title":"Cancer Cell"},{"issue":"1","key":"6171_CR90","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A (2025) Cancer statistics, 2025. CA Cancer J Clin 75(1):10\u201345. https:\/\/doi.org\/10.3322\/caac.21871","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"6171_CR91","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1210\/en.2006-1223","volume":"148","author":"U Simanainen","year":"2007","unstructured":"Simanainen U, Allan CM, Lim P, McPherson S, Jimenez M, Zajac JD, Davey RA, Handelsman DJ (2007) Disruption of prostate epithelial androgen receptor impedes prostate lobe-specific growth and function. Endocrinology 148(5):2264\u20132272. https:\/\/doi.org\/10.1210\/en.2006-1223","journal-title":"Endocrinology"},{"key":"6171_CR92","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.21856","volume":"6","author":"PJ Skene","year":"2017","unstructured":"Skene PJ, Henikoff S (2017) An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites. Elife 6:e21856. https:\/\/doi.org\/10.7554\/eLife.21856","journal-title":"Elife"},{"issue":"2","key":"6171_CR93","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ccell.2019.06.009","volume":"36","author":"W Su","year":"2019","unstructured":"Su W, Han HH, Wang Y, Zhang B, Zhou B, Cheng Y, Rumandla A, Gurrapu S, Chakraborty G, Su J, Yang G, Liang X, Wang G, Rosen N, Scher HI, Ouerfelli O, Giancotti FG (2019) The polycomb repressor complex 1 drives double-negative prostate cancer metastasis by coordinating stemness and immune suppression. Cancer Cell 36(2):139-155.e10. https:\/\/doi.org\/10.1016\/j.ccell.2019.06.009","journal-title":"Cancer Cell"},{"key":"6171_CR94","doi-asserted-by":"publisher","DOI":"10.1101\/2023.03.28.534644","author":"X Sun","year":"2025","unstructured":"Sun X, Gupta S, Tong A, Kuchroo M, Bhaskar D, Liu C, Venkat A, Juan BPS, Rangel L, Rodriguez V, Lock JG, Chaffer CL, Krishnaswamy S (2025) Revealing dynamic temporal trajectories and underlying regulatory networks with Cflows. Biorxiv. https:\/\/doi.org\/10.1101\/2023.03.28.534644","journal-title":"Biorxiv"},{"issue":"8","key":"6171_CR95","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.trecan.2020.04.010","volume":"6","author":"U Swami","year":"2020","unstructured":"Swami U, McFarland TR, Nussenzveig R, Agarwal N (2020) Advanced prostate cancer: treatment advances and future directions. Trends Cancer 6(8):702\u2013715. https:\/\/doi.org\/10.1016\/j.trecan.2020.04.010","journal-title":"Trends Cancer"},{"issue":"19","key":"6171_CR96","doi-asserted-by":"publisher","first-page":"4875","DOI":"10.1158\/0008-5472.CAN-12-2217","volume":"72","author":"C Swanton","year":"2012","unstructured":"Swanton C (2012) Intratumor heterogeneity: evolution through space and time. Cancer Res 72(19):4875\u20134882. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-2217","journal-title":"Cancer Res"},{"key":"6171_CR97","doi-asserted-by":"publisher","unstructured":"Taavitsainen S, Engedal N, Cao S, Handle F, Erickson A, Prekovic S, Wetterskog D, Tolonen T, Vuorinen EM, Kiviaho A, N\u00e4tkin R, H\u00e4kkinen T, Devlies W, Henttinen S, Kaarij\u00e4rvi R, Lahnalampi M, Kaljunen H, Nowakowska K, Syv\u00e4l\u00e4 H, Bl\u00e4uer M, Urbanucci A (2021) Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse. Nature communications 12(1):5307. https:\/\/doi.org\/10.1038\/s41467-021-25624-1","DOI":"10.1038\/s41467-021-25624-1"},{"issue":"5","key":"6171_CR98","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.stem.2014.09.008","volume":"15","author":"BD Tarlow","year":"2014","unstructured":"Tarlow BD, Pelz C, Naugler WE, Wakefield L, Wilson EM, Finegold MJ, Grompe M (2014) Bipotential adult liver progenitors are derived from chronically injured mature hepatocytes. Cell Stem Cell 15(5):605\u2013618. https:\/\/doi.org\/10.1016\/j.stem.2014.09.008","journal-title":"Cell Stem Cell"},{"key":"6171_CR99","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1146\/annurev-med-051517-011947","volume":"70","author":"MY Teo","year":"2019","unstructured":"Teo MY, Rathkopf DE, Kantoff P (2019) Treatment of advanced prostate cancer. Annu Rev Med 70:479\u2013499. https:\/\/doi.org\/10.1146\/annurev-med-051517-011947","journal-title":"Annu Rev Med"},{"issue":"2","key":"6171_CR100","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.stem.2016.01.001","volume":"18","author":"PW Tetteh","year":"2016","unstructured":"Tetteh PW, Basak O, Farin HF, Wiebrands K, Kretzschmar K, Begthel H, van den Born M, Korving J, de Sauvage F, van Es JH, van Oudenaarden A, Clevers H (2016) Replacement of lost Lgr5-positive stem cells through plasticity of their enterocyte-lineage daughters. Cell Stem Cell 18(2):203\u2013213. https:\/\/doi.org\/10.1016\/j.stem.2016.01.001","journal-title":"Cell Stem Cell"},{"issue":"1","key":"6171_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51156-5","volume":"15","author":"VB Venkadakrishnan","year":"2024","unstructured":"Venkadakrishnan VB, Presser AG, Singh R, Booker MA, Traphagen NA, Weng K, Voss NCE, Mahadevan NR, Mizuno K, Puca L, Idahor O, Ku S-Y, Bakht MK, Borah AA, Herbert ZT, Tolstorukov MY, Barbie DA, Rickman DS, Brown M, Beltran H (2024) Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes. Nat Commun 15(1):6779. https:\/\/doi.org\/10.1038\/s41467-024-51156-5","journal-title":"Nat Commun"},{"issue":"3","key":"6171_CR102","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ajur.2019.10.003","volume":"7","author":"RE Vickman","year":"2020","unstructured":"Vickman RE, Franco OE, Moline DC, Vander Griend DJ, Thumbikat P, Hayward SW (2020) The role of the androgen receptor in prostate development and benign prostatic hyperplasia: a review. Asian J Urol 7(3):191\u2013202. https:\/\/doi.org\/10.1016\/j.ajur.2019.10.003","journal-title":"Asian J Urol"},{"issue":"7","key":"6171_CR103","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41576-020-0223-2","volume":"21","author":"DE Wagner","year":"2020","unstructured":"Wagner DE, Klein AM (2020) Lineage tracing meets single-cell omics: opportunities and challenges. Nat Rev Genet 21(7):410\u2013427. https:\/\/doi.org\/10.1038\/s41576-020-0223-2","journal-title":"Nat Rev Genet"},{"issue":"7","key":"6171_CR104","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.cell.2011.05.026","volume":"145","author":"X Wang","year":"2011","unstructured":"Wang X, Ouyang H, Yamamoto Y, Kumar PA, Wei TS, Dagher R, Vincent M, Lu X, Bellizzi AM, Ho KY, Crum CP, Xian W, McKeon F (2011) Residual embryonic cells as precursors of a Barrett\u2019s-like metaplasia. Cell 145(7):1023\u20131035. https:\/\/doi.org\/10.1016\/j.cell.2011.05.026","journal-title":"Cell"},{"issue":"31","key":"6171_CR105","doi-asserted-by":"publisher","first-page":"12679","DOI":"10.1073\/pnas.0704940104","volume":"104","author":"CT Wu","year":"2007","unstructured":"Wu CT, Altuwaijri S, Ricke WA, Huang SP, Yeh S, Zhang C, Niu Y, Tsai MY, Chang C (2007) Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor. Proc Natl Acad Sci U S A 104(31):12679\u201312684. https:\/\/doi.org\/10.1073\/pnas.0704940104","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"6171_CR106","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41588-019-0554-0","volume":"52","author":"G Xu","year":"2020","unstructured":"Xu G, Chhangawala S, Cocco E, Razavi P, Cai Y, Otto JE, Ferrando L, Selenica P, Ladewig E, Chan C, Da Cruz Paula A, Witkin M, Cheng Y, Park J, Serna-Tamayo C, Zhao H, Wu F, Sallaku M, Qu X, Toska E (2020) ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer. Nat Genet 52(2):198\u2013207. https:\/\/doi.org\/10.1038\/s41588-019-0554-0","journal-title":"Nat Genet"},{"issue":"8","key":"6171_CR107","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1158\/2159-8290.CD-23-0539","volume":"14","author":"Y Xu","year":"2024","unstructured":"Xu Y, Yang Y, Wang Z, Sj\u00f6str\u00f6m M, Jiang Y, Tang Y, Cheng S, Deng S, Wang C, Gonzalez J, Johnson NA, Li X, Li X, Metang LA, Mukherji A, Xu Q, Tirado CR, Wainwright G, Yu X, Barnes S, Mu P (2024) ZNF397 deficiency triggers TET2-driven lineage plasticity and AR-targeted therapy resistance in prostate cancer. Cancer Discov 14(8):1496\u20131521. https:\/\/doi.org\/10.1158\/2159-8290.CD-23-0539","journal-title":"Cancer Discov"},{"issue":"1","key":"6171_CR108","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07361-1","volume":"16","author":"D Yanushko","year":"2025","unstructured":"Yanushko D, German Falcon B, El Bizri R, Pervizou D, Dolgos R, Keime C, Ye T, Thibault-Carpentier C, Le Magnen C, Henri S, Laverny G, Metzger D (2025) P53-loss induced prostatic epithelial cell plasticity and invasion is driven by a crosstalk with the tumor microenvironment. Cell Death Dis 16(1):46. https:\/\/doi.org\/10.1038\/s41419-025-07361-1","journal-title":"Cell Death Dis"},{"issue":"6","key":"6171_CR109","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.cell.2014.03.060","volume":"157","author":"D Yimlamai","year":"2014","unstructured":"Yimlamai D, Christodoulou C, Galli GG, Yanger K, Pepe-Mooney B, Gurung B, Shrestha K, Cahan P, Stanger BZ, Camargo FD (2014) Hippo pathway activity influences liver cell fate. Cell 157(6):1324\u20131338. https:\/\/doi.org\/10.1016\/j.cell.2014.03.060","journal-title":"Cell"},{"issue":"4","key":"6171_CR110","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.ccell.2020.03.001","volume":"37","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Zhou C, Li X, Barnes SD, Deng S, Hoover E, Chen CC, Lee YS, Zhang Y, Wang C, Metang LA, Wu C, Tirado CR, Johnson NA, Wongvipat J, Navrazhina K, Cao Z, Choi D, Huang CH, Linton E, Mu P (2020) Loss of CHD1 promotes heterogeneous mechanisms of resistance to AR-targeted therapy via chromatin dysregulation. Cancer Cell 37(4):584-598.e11. https:\/\/doi.org\/10.1016\/j.ccell.2020.03.001","journal-title":"Cancer Cell"},{"issue":"18","key":"6171_CR111","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1016\/j.devcel.2025.07.002","volume":"60","author":"X Zhang","year":"2025","unstructured":"Zhang X, Du Y, Behrens A, Lan L (2025) Emerging insights into lineage plasticity in pancreatic cancer initiation, progression, and therapy resistance. Dev Cell 60(18):2391\u20132406. https:\/\/doi.org\/10.1016\/j.devcel.2025.07.002","journal-title":"Dev Cell"},{"issue":"9","key":"6171_CR112","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1158\/2159-8290.CD-19-1352","volume":"10","author":"D Zhao","year":"2020","unstructured":"Zhao D, Cai L, Lu X, Liang X, Li J, Chen P, Ittmann M, Shang X, Jiang S, Li H, Meng C, Flores I, Song JH, Horner JW, Lan Z, Wu CJ, Li J, Chang Q, Chen KC, Wang G, DePinho RA (2020) Chromatin regulator CHD1 remodels the immunosuppressive tumor microenvironment in PTEN-deficient prostate cancer. Cancer Discov 10(9):1374\u20131387. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-1352","journal-title":"Cancer Discov"},{"issue":"7642","key":"6171_CR113","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nature21357","volume":"542","author":"D Zhao","year":"2017","unstructured":"Zhao D, Lu X, Wang G, Lan Z, Liao W, Li J, Liang X, Chen JR, Shah S, Shang X, Tang M, Deng P, Dey P, Chakravarti D, Chen P, Spring DJ, Navone NM, Troncoso P, Zhang J, Wang YA, DePinho RA (2017) Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer. Nature 542(7642):484\u2013488. https:\/\/doi.org\/10.1038\/nature21357","journal-title":"Nature"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-026-06171-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06171-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06171-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:17:29Z","timestamp":1780625849000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-026-06171-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":113,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6171"],"URL":"https:\/\/doi.org\/10.1007\/s00018-026-06171-8","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"27 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"P.M. served as a scientific consultant to Accutar Biotechnology, Inc. No other authors have COI to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"During the preparation of this work the author(s) used ChatGPT in order to proofread and correct grammar and typographical errors. After using this tool\/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of AI-assisted technologies in the manuscript preparation process"}}],"article-number":"236"}}